Logo image of LIF

LIFE360 INC (LIF) Stock Fundamental Analysis

NASDAQ:LIF - Nasdaq - US5322061095 - Common Stock - Currency: USD

63.04  +0.24 (+0.38%)

After market: 63.04 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIF. LIF was compared to 282 industry peers in the Software industry. LIF has an excellent financial health rating, but there are some minor concerns on its profitability. LIF shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year LIF was profitable.
LIF had a positive operating cash flow in the past year.
LIF Yearly Net Income VS EBIT VS OCF VS FCFLIF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

LIF has a Return On Assets of 2.11%. This is in the better half of the industry: LIF outperforms 69.15% of its industry peers.
With a decent Return On Equity value of 2.55%, LIF is doing good in the industry, outperforming 69.15% of the companies in the same industry.
LIF has a Return On Invested Capital of 0.12%. This is in the better half of the industry: LIF outperforms 63.83% of its industry peers.
Industry RankSector Rank
ROA 2.11%
ROE 2.55%
ROIC 0.12%
ROA(3y)-12.26%
ROA(5y)N/A
ROE(3y)-16.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIF Yearly ROA, ROE, ROICLIF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

LIF's Profit Margin of 2.42% is fine compared to the rest of the industry. LIF outperforms 68.79% of its industry peers.
LIF has a Operating Margin of 0.15%. This is in the better half of the industry: LIF outperforms 63.83% of its industry peers.
Looking at the Gross Margin, with a value of 76.27%, LIF is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
In the last couple of years the Gross Margin of LIF has declined.
Industry RankSector Rank
OM 0.15%
PM (TTM) 2.42%
GM 76.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5YN/A
LIF Yearly Profit, Operating, Gross MarginsLIF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIF is destroying value.
The number of shares outstanding for LIF has been increased compared to 1 year ago.
There is no outstanding debt for LIF. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LIF Yearly Shares OutstandingLIF Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
LIF Yearly Total Debt VS Total AssetsLIF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

LIF has an Altman-Z score of 37.04. This indicates that LIF is financially healthy and has little risk of bankruptcy at the moment.
LIF has a better Altman-Z score (37.04) than 96.81% of its industry peers.
LIF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 37.04
ROIC/WACC0.01
WACC11.03%
LIF Yearly LT Debt VS Equity VS FCFLIF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 3.38 indicates that LIF has no problem at all paying its short term obligations.
LIF's Current ratio of 3.38 is fine compared to the rest of the industry. LIF outperforms 78.72% of its industry peers.
LIF has a Quick Ratio of 3.25. This indicates that LIF is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.25, LIF is in the better half of the industry, outperforming 78.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.38
Quick Ratio 3.25
LIF Yearly Current Assets VS Current LiabilitesLIF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

7

3. Growth

3.1 Past

LIF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.03%, which is quite impressive.
The Revenue has grown by 21.99% in the past year. This is a very strong growth!
Measured over the past years, LIF shows a very strong growth in Revenue. The Revenue has been growing by 48.85% on average per year.
EPS 1Y (TTM)85.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.79%
Revenue 1Y (TTM)21.99%
Revenue growth 3Y48.85%
Revenue growth 5YN/A
Sales Q2Q%32.47%

3.2 Future

LIF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.50% yearly.
LIF is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.84% yearly.
EPS Next Y142.86%
EPS Next 2Y110.75%
EPS Next 3Y93.63%
EPS Next 5Y39.5%
Revenue Next Year25.97%
Revenue Next 2Y24.04%
Revenue Next 3Y22.02%
Revenue Next 5Y14.84%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LIF Yearly Revenue VS EstimatesLIF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
LIF Yearly EPS VS EstimatesLIF Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2101.33, the valuation of LIF can be described as expensive.
LIF's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of LIF to the average of the S&P500 Index (26.19), we can say LIF is valued expensively.
The Price/Forward Earnings ratio is 166.00, which means the current valuation is very expensive for LIF.
Based on the Price/Forward Earnings ratio, LIF is valued a bit more expensive than the industry average as 63.83% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, LIF is valued quite expensively.
Industry RankSector Rank
PE 2101.33
Fwd PE 166
LIF Price Earnings VS Forward Price EarningsLIF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 500 1K 1.5K 2K

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LIF is on the same level as its industry peers.
LIF's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 169.76
EV/EBITDA 425.67
LIF Per share dataLIF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LIF's earnings are expected to grow with 93.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)14.71
PEG (5Y)N/A
EPS Next 2Y110.75%
EPS Next 3Y93.63%

0

5. Dividend

5.1 Amount

LIF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIFE360 INC

NASDAQ:LIF (5/29/2025, 8:00:02 PM)

After market: 63.04 0 (0%)

63.04

+0.24 (+0.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06
Inst Owners13.66%
Inst Owner Change61.67%
Ins Owners1.83%
Ins Owner Change-17.62%
Market Cap4.82B
Analysts82
Price Target54.91 (-12.9%)
Short Float %3.63%
Short Ratio4.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)257.59%
Min EPS beat(2)165.14%
Max EPS beat(2)350.05%
EPS beat(4)3
Avg EPS beat(4)151.03%
Min EPS beat(4)-60.56%
Max EPS beat(4)350.05%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)0.95%
Revenue beat(4)1
Avg Revenue beat(4)-1.82%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)0.95%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.22%
PT rev (3m)-1.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-208.33%
EPS NY rev (1m)-8.33%
EPS NY rev (3m)-60.71%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)2.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 2101.33
Fwd PE 166
P/S 12.16
P/FCF 169.76
P/OCF 141.96
P/B 12.82
P/tB 24.29
EV/EBITDA 425.67
EPS(TTM)0.03
EY0.05%
EPS(NY)0.38
Fwd EY0.6%
FCF(TTM)0.37
FCFY0.59%
OCF(TTM)0.44
OCFY0.7%
SpS5.19
BVpS4.92
TBVpS2.6
PEG (NY)14.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 2.55%
ROCE 0.16%
ROIC 0.12%
ROICexc 0.22%
ROICexgc 1.34%
OM 0.15%
PM (TTM) 2.42%
GM 76.27%
FCFM 7.16%
ROA(3y)-12.26%
ROA(5y)N/A
ROE(3y)-16.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5YN/A
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 53.79%
Cap/Sales 1.4%
Interest Coverage 250
Cash Conversion 310.73%
Profit Quality 296%
Current Ratio 3.38
Quick Ratio 3.25
Altman-Z 37.04
F-Score7
WACC11.03%
ROIC/WACC0.01
Cap/Depr(3y)28.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.79%
EPS Next Y142.86%
EPS Next 2Y110.75%
EPS Next 3Y93.63%
EPS Next 5Y39.5%
Revenue 1Y (TTM)21.99%
Revenue growth 3Y48.85%
Revenue growth 5YN/A
Sales Q2Q%32.47%
Revenue Next Year25.97%
Revenue Next 2Y24.04%
Revenue Next 3Y22.02%
Revenue Next 5Y14.84%
EBIT growth 1Y73.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year560.23%
EBIT Next 3Y127.38%
EBIT Next 5Y82.67%
FCF growth 1Y418.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y333.44%
OCF growth 3YN/A
OCF growth 5YN/A